Cargando…

Wilson’s Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States

The economic and health care use burdens of Wilson’s disease (WD) are unknown. In this study, we aimed to quantify this health care resource use and economic burden. We performed a retrospective case‐control analysis of individuals in the Truven Health MarketScan Commercial Claims database (2007‐201...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rustgi, Vinod K., Gupta, Kapil, Tait, Christopher, Bhurwal, Abhishek, Kabaria, Savan, Catalano, Carolyn, Li, You, Minacapelli, Carlos D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793990/ https://www.ncbi.nlm.nih.gov/pubmed/34559472 http://dx.doi.org/10.1002/hep4.1812

Ejemplares similares

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Acute kidney injury and hepatorenal syndrome in cirrhosis
por: Gupta, Kapil, et al.
Publicado: (2021)

In-Hospital Mortality and Prediction in an Urban U.S. Population With COVID-19
por: Rustgi, Vinod, et al.
Publicado: (2020)

Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery
por: Yin, Yue Sandra, et al.
Publicado: (2022)

Timing of endoscopic retrograde cholangiopancreatography in acute biliary pancreatitis without cholangitis: a nationwide inpatient cohort study
por: Kabaria, Savan, et al.
Publicado: (2021)

COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations
por: Bhurwal, Abhishek, et al.
Publicado: (2021)

Demographics and Outcomes Related to Wilson’s Disease Patients: A Nationwide Inpatient Cohort Study
por: Patel, Ankoor H, et al.
Publicado: (2023)

Surgery in Nonalcoholic Cirrhosis: Clinical Outcomes, Healthcare Utilization, and Cost Analysis
por: Tait, Christopher, et al.
Publicado: (2023)

Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real‐World Claims Analysis
por: Rustgi, Vinod K., et al.
Publicado: (2020)

Reduction in Gastrointestinal Cancers in Cirrhotic Patients Receiving Rifaximin vs Lactulose Only Therapy for Hepatic Encephalopathy
por: Patel, Ankoor H, et al.
Publicado: (2023)

The Spontaneous Regression of Primary Gastrointestinal Malignancies: An Observational Review
por: Minacapelli, Carlos D, et al.
Publicado: (2022)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
por: Patel, Ankoor H., et al.
Publicado: (2023)

Gastrointestinal Findings in a Patient With COVID-19
por: Makar, Michael, et al.
Publicado: (2020)

Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States
por: Krishnarajah, Girishanthy, et al.
Publicado: (2014)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

2145. Economic Burden of Congenital Cytomegalovirus Infection in Commercially- and Medicaid-insured Patients in the United States
por: Diaz-Decaro, John D, et al.
Publicado: (2022)

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis
por: Placzek, Hilary, et al.
Publicado: (2015)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

Economic burden related to fistulas or strictures among commercially insured patients with Crohn’s disease in the United States
por: Fan, Yanni, et al.
Publicado: (2023)

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States
por: Lee, Tsung-Ying, et al.
Publicado: (2022)

The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid
por: Jacobson, Jed J, et al.
Publicado: (2012)

Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease
por: Elsaid, Mohamed I., et al.
Publicado: (2022)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States
por: Silverman, Stuart, et al.
Publicado: (2022)

Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

Economic Burden of Irritable Bowel Syndrome with Constipation: A Retrospective Analysis of Health Care Costs in a Commercially Insured Population
por: Doshi, Jalpa A., et al.
Publicado: (2014)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Hepatic Silicone Granulomas Secondary to Ruptured Breast Implants: A Report of Two Cases
por: Hudacko, Rachel, et al.
Publicado: (2019)

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013
por: McPherson, Timothy, et al.
Publicado: (2016)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Cost Burden of Endothelial Keratoplasty in Fuchs Endothelial Dystrophy: Real-World Analysis of a Commercially Insured US Population (2014–2019)
por: Dhaliwal, Deepinder K, et al.
Publicado: (2022)

Cost of Outpatient Arthroscopic Anterior Cruciate Ligament Reconstruction Among Commercially Insured Patients in the United States, 2005-2013
por: Herzog, Mackenzie M., et al.
Publicado: (2017)

The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States
por: Ogbomo, Adesuwa, et al.
Publicado: (2022)

Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Postpartum care visits among commercially insured women in the United States
por: Butwick, Alexander J., et al.
Publicado: (2022)

Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
por: Ludwig, Cassie A., et al.
Publicado: (2023)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_saainmuidjun7c0jk0ipe5if1d